Scientific Literature Search

Source record

Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.

Widnell KL, Comella C.

Mov Disord · 2005-01-01

DOI: 10.1002/mds.20461PMID: 15822107

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.

Olanow CW, Jankovic J.

Mov Disord · 2005-01-01

DOI: 10.1002/mds.20457PMID: 15822111

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The effect of conventional and sustained delivery of levodopa on SH-SY5Y neuroblastoma cells.

Martin TM, Benghuzzi H, Tucci M.

Biomed Sci Instrum · 2005-01-01

PMID: 15850136

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Ropinirole in the treatment of restless legs syndrome.

Kakar RS, Kushida CA.

Expert Rev Neurother · 2005-01-01

DOI: 10.1586/14737175.5.1.35PMID: 15853472

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits.

Ahmadi A, Naderi G, Asgary S.

Drugs Exp Clin Res · 2005-01-01

PMID: 15921023

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effectiveness of exercise therapy: a best-evidence summary of systematic reviews.

Smidt N, de Vet HC, Bouter LM, Dekker J, Arendzen JH, de Bie RA, Bierma-Zeinstra SM, Helders PJ, Keus SH, Kwakkel G, Lenssen T, Oostendorp RA, Ostelo RW, Reijman M, Terwee CB, Theunissen C, Thomas S, van Baar ME, van 't Hul A, van Peppen RP, Verhagen A, van der Windt DA, Exercise Therapy Group.

Aust J Physiother · 2005-01-01

DOI: 10.1016/s0004-9514(05)70036-2PMID: 15924510

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.

Lemke MR, Brecht HM, Koester J, Kraus PH, Reichmann H.

J Neuropsychiatry Clin Neurosci · 2005-01-01

DOI: 10.1176/jnp.17.2.214PMID: 15939976

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Functional brain activity in patients with Parkinson's disease during amantadin-sulfate therapy].

Arakelian RK, Nerobkova LN, Katunina EA, Val'dman EA, Kapitsa IG, Voronina TA, Avakian GN, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova · 2005-01-01

PMID: 15875939

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

Andres RH, Huber AW, Schlattner U, Pérez-Bouza A, Krebs SH, Seiler RW, Wallimann T, Widmer HR.

Neuroscience · 2005-01-01

DOI: 10.1016/j.neuroscience.2005.03.004PMID: 15890457

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.

Hauser RA, Schwarzschild MA.

Drugs Aging · 2005-01-01

DOI: 10.2165/00002512-200522060-00002PMID: 15974638

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Tolcapone treatment of late stages of Parkinson's disease].

Fedorova NV, Chigir' IP, Krivonos OV.

Zh Nevrol Psikhiatr Im S S Korsakova · 2005-01-01

PMID: 15984185

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

Blandini F.

CNS Drug Rev · 2005-01-01

DOI: 10.1111/j.1527-3458.2005.tb00269.xPMID: 16007239

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.418 articles found

Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.

Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.

The effect of conventional and sustained delivery of levodopa on SH-SY5Y neuroblastoma cells.

Ropinirole in the treatment of restless legs syndrome.

Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits.

Effectiveness of exercise therapy: a best-evidence summary of systematic reviews.

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.

[Functional brain activity in patients with Parkinson's disease during amantadin-sulfate therapy].

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience.

[Tolcapone treatment of late stages of Parkinson's disease].

Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?

Filters